The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I trial of enzalutamide in combination with gemcitabine and nab-paclitaxel for the treatment of advanced pancreatic cancer.
 
Amit Mahipal
Speakers' Bureau - Dendreon (I)
Research Funding - Celgene; Immune Design; Karyopharm Therapeutics; Novartis
 
Gregory M. Springett
Stock and Other Ownership Interests - Exelixis; Pharmacyclics
 
Nancy Burke
No Relationships to Disclose
 
Barbara Bertels
No Relationships to Disclose
 
Georgine Wapinsky
No Relationships to Disclose
 
Khaldoun Almhanna
Consulting or Advisory Role - Lilly
Speakers' Bureau - Genentech
 
Richard D. Kim
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Lilly
Speakers' Bureau - Bristol-Myers Squibb; Sanofi
Research Funding - Bayer; Novartis